Abstract
Almost a quarter of pediatric patients with acute lymphoblastic leukemia (ALL) suffer from relapses. The biological mechanisms underlying therapy response and development of relapses have remained unclear. In an attempt to better understand this phenomenon, we have analyzed 41 matched diagnosis–relapse pairs of ALL patients using genome-wide expression arrays (82 arrays) on purified leukemic cells. In roughly half of the patients, very few differences between diagnosis and relapse samples were found (‘stable group’), suggesting that mostly extra-leukemic factors (for example, drug distribution, drug metabolism, compliance) contributed to the relapse. Therefore, we focused our further analysis on 20 sample pairs with clear differences in gene expression (‘skewed group’), reasoning that these would allow us to better study the biological mechanisms underlying relapsed ALL. After finding the differences between diagnosis and relapse pairs in this group, we identified four major gene clusters corresponding to several pathways associated with changes in cell cycle, DNA replication, recombination and repair, as well as B-cell developmental genes. We also identified cancer genes commonly associated with colon carcinomas and ubiquitination to be upregulated in relapsed ALL. Thus, about half of the relapses are due to the selection or emergence of a clone with deregulated expression of genes involved in pathways that regulate B-cell signaling, development, cell cycle, cellular division and replication.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pieters R, Carroll WL . Biology and treatment of acute lymphoblastic leukemia. Pediatr Clin North Am 2008; 55: 1–20, ix.
Carroll WL, Bhojwani D, Min DJ, Moskowitz N, Raetz EA . Childhood acute lymphoblastic leukemia in the age of genomics. Pediatr Blood Cancer 2006; 46: 570–578.
Gaynon PS . Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol 2005; 131: 579–587.
Henderson MJ, Choi S, Beesley AH, Sutton R, Venn NC, Marshall GM et al. Mechanism of relapse in pediatric acute lymphoblastic leukemia. Cell Cycle 2008; 7: 1315–1320.
Beesley AH, Cummings AJ, Freitas JR, Hoffmann K, Firth MJ, Ford J et al. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br J Haematol 2005; 131: 447–456.
Bhojwani D, Kang H, Moskowitz NP, Min DJ, Lee H, Potter JW et al. Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 2006; 108: 711–717.
Choi S, Henderson MJ, Kwan E, Beesley AH, Sutton R, Bahar AY et al. Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood 2007; 110: 632–639.
Ferrando AA, Look AT . Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol 2003; 40: 274–280.
Ferrando AA, Look AT . DNA microarrays in the diagnosis and management of acute lymphoblastic leukemia. Int J Hematol 2004; 80: 395–400.
Hoffmann K, Firth MJ, Beesley AH, de Klerk NH, Kees UR . Translating microarray data for diagnostic testing in childhood leukaemia. BMC Cancer 2006; 6: 229.
Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 2004; 351: 533–542.
Palomero T, McKenna K, J ON, Galinsky I, Stone R, Suzukawa K et al. Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias. Leukemia 2006; 20: 1963–1966.
Raetz EA, Perkins SL, Bhojwani D, Smock K, Philip M, Carroll WL et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer 2006; 47: 130–140.
Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133–143.
Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41–47.
Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood 2004; 104: 3679–3687.
Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003; 102: 2951–2959.
Staal FJ, van der Burg M, Wessels LF, Barendregt BH, Baert MR, van den Burg CM et al. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers. Leukemia 2003; 17: 1324–1332.
de Ridder D, van der Linden CE, Schonewille T, Dik WA, Reinders MJ, van Dongen JJ et al. Purity for clarity: the need for purification of tumor cells in DNA microarray studies. Leukemia 2005; 19: 618–627.
Staal FJ, Cario G, Cazzaniga G, Haferlach T, Heuser M, Hofmann WK et al. Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks. Leukemia 2006; 20: 1385–1392.
Staal FJ, Weerkamp F, Baert MR, van den Burg CM, van Noort M, de Haas EF et al. Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion. J Immunol 2004; 172: 1099–1108.
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249–264.
Bolstad BM, Irizarry RA, Astrand M, Speed TP . A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185–193.
Tusher VG, Tibshirani R, Chu G . Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–5121.
Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000; 14: 1426–1435.
Pongers-Willemse MJ, Seriu T, Stolz F, d’Aniello E, Gameiro P, Pisa P et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 110–118.
Szczepanski T, van der Velden VHJ, Hoogeveen PG, De Bie M, Jacobs DCH, Van Wering ER et al. V{delta}2-J{alpha} gene rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells. Blood 2004; 103: 3798–3804.
Szczepanski T, Willemse MJ, van Wering ER, van Weerden JF, Kamps WA, van Dongen JJM . Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia 2001; 15: 1415–1423.
van Dongen JJM, Langerak AW, Bruggemann M, Evans PAS, Hummel M, Lavender FL et al. Design and standardization of PCR primers and protocols for detection of clonal immunogloulin and T-cell receptor gene recombinations in suspect lymphoproliferations. Leukemia 2003; 17: 2257–2317.
Szczepanski T, van der Velden VH, Raff T, Jacobs DC, van Wering ER, Bruggemann M et al. Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL. Leukemia 2003; 17: 2149–2156.
Szczepanski T, Willemse MJ, Brinkhof B, van Wering ER, van der Burg M, van Dongen JJ . Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease. Blood 2002; 99: 2315–2323.
Staal FJ, Luis TC, Tiemessen MM . WNT signalling in the immune system: WNT is spreading its wings. Nat Rev 2008; 8: 581–593.
Weerkamp F, van Dongen JJ, Staal FJ . Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia. Leukemia 2006; 20: 1197–1205.
Kirschner-Schwabe R, Lottaz C, Todling J, Rhein P, Karawajew L, Eckert C et al. Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia. Clin Cancer Res 2006; 12: 4553–4561.
Beesley AH, Weller RE, Kees UR . The role of BSG (CD147) in acute lymphoblastic leukaemia and relapse. Br J Haematol 2008; 142: 1000–1002.
Boag JM, Beesley AH, Firth MJ, Freitas JR, Ford J, Hoffmann K et al. Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia. Leukemia 2006; 20: 1731–1737.
Hoffmann K, Firth MJ, Beesley AH, Freitas JR, Ford J, Senanayake S et al. Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index. Br J Haematol 2008; 140: 656–664.
Mullighan CG, Phillips LA, Su X, Ma J, Miller CB, Shurtleff SA et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science (New York, NY) 2008; 322: 1377–1380.
Davies DL, Bouldin D . A cluster separation measure. IEEE Trans Pattern Anal Mach Intell 1979; 1: 224–227.
Acknowledgements
We thank Patricia Hoogeveen for technical assistance and Dr Ton Langerak for stimulating discussions. We also thank the Dutch Childhood Oncology Group (head: Dr Valerie de Haas) for help in providing samples and patient data.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Supplementary information
Rights and permissions
About this article
Cite this article
Staal, F., de Ridder, D., Szczepanski, T. et al. Genome-wide expression analysis of paired diagnosis–relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype. Leukemia 24, 491–499 (2010). https://doi.org/10.1038/leu.2009.286
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2009.286
Keywords
This article is cited by
-
The positive feedback loop of MAD2L1/TYK2/STAT3 induces progression in B-cell acute lymphoblastic leukaemia
Journal of Cancer Research and Clinical Oncology (2023)
-
The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance
Molecular and Cellular Biochemistry (2021)
-
Nucleotide excision repair is a predictor of early relapse in pediatric acute lymphoblastic leukemia
BMC Medical Genomics (2018)
-
Overexpression of the giant FAT1 cadherin gene and its prognostic significance in de novo acute leukaemia patients
Comparative Clinical Pathology (2017)
-
Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer
Tumor Biology (2014)